The 17 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 48.36, with a high estimate of 57.04 and a low estimate of 38.62. The median estimate represents a +17.13% increase from the last price of 41.29.
The current consensus among 20 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.87
Reporting Date Oct 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.